The function of chaperones in the radioresistance of glioblastoma: a new insight into the current knowledge
Brain Tumor Pathology · 2025
DOI: 10.1007/s10014-025-00501-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain Tumor Pathology, 2025. Verfasst von Reza Arefnezhd und 12 weiteren Autor:innen. Beteiligte Einrichtung: Coenzyme R Research Institute, Tehran, Iran. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Radiation Tolerance, Molecular Chaperones. Die Arbeit nennt 95 Literaturangaben.
Abstract (Originalsprache)
Radiotherapy remains a cornerstone of brain tumor treatment; however, its effectiveness is frequently undermined by the development of radioresistance. This review highlights the pivotal role of molecular chaperones in promoting radioresistance and explores the potential to increase radioresistance in brain cancers, particularly glioblastoma (GBM). Among chaperones, heat shock proteins (HSPs), such as HSP70 and HSP90, have been identified as key contributors to radioresistance, acting through mechanisms that include the maintenance of protein homeostasis, enhancement of DNA repair processes, and protection of cancer stem cells. Specifically, HSP70 and HSP90 are crucial in stabilizing oncogenic proteins and preventing apoptosis, thus enabling tumor survival during radiotherapy. Also, HSP27 and GRP78 are involved in the radioresistance of brain tumors mainly by suppressing cell death and enhancing tumor stem cell propagation. Emerging evidence also suggests that targeting these chaperones, in combination with radiotherapy, can enhance tumor radiosensitivity, offering promising therapeutic strategies. Recent studies have revealed novel aspects of chaperone-mediated autophagy and interaction with non-coding RNAs, providing deeper insights into the molecular mechanisms underlying radioresistance. This review also addresses the potential of combining chaperone-targeted therapies, such as HSP90 inhibitors, with radiotherapy to overcome resistance. Ultimately, understanding these mechanisms may pave the way for innovative clinical applications and personalized therapeutic approaches in brain tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Coenzyme R Research Institute, Tehran, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Medical Physics, School of Medicine, Mashhad University of Medical Science, Mashhad, Iran.
- Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Faculty of Medicine, Isfahan University of Medical Science, Isfahan, Iran.
Zitieren
APA
Arefnezhd, R., Chahardehi, A. M., Asadi, A., Shadravan, M. M., Shariati, A., Rezaee, A., Radmanesh, M., Nazarian, M., Helfi, M., Soleimani Meigoli, M. S., Motedayyen, H., Rezaei-Tazangi, F., & Tavakoli, M. R. (2025). The function of chaperones in the radioresistance of glioblastoma: a new insight into the current knowledge. Brain Tumor Pathology. https://doi.org/10.1007/s10014-025-00501-7
Vancouver
Arefnezhd R, Chahardehi AM, Asadi A, Shadravan MM, Shariati A, Rezaee A, et al. The function of chaperones in the radioresistance of glioblastoma: a new insight into the current knowledge. Brain Tumor Pathology. 2025. doi:10.1007/s10014-025-00501-7
BibTeX
@article{Arefnezhd2025,
author = {Arefnezhd, Reza and Chahardehi, Amir Modarresi and Asadi, Amirmasoud and Shadravan, Mahammad Mehdi and Shariati, Abbas and Rezaee, Aryan and Radmanesh, Mehrsa and Nazarian, Mohammadreza and Helfi, Maryam and Soleimani Meigoli, Mohammad Saeed and Motedayyen, Hossein and Rezaei-Tazangi, Fatemeh and Tavakoli, Marziye Ranjbar},
title = {The function of chaperones in the radioresistance of glioblastoma: a new insight into the current knowledge},
journal = {Brain Tumor Pathology},
year = {2025},
doi = {10.1007/s10014-025-00501-7}
}
EUVIMED